Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F9SG
|
|||
Former ID |
DAP001224
|
|||
Drug Name |
Dexfenfluramine
|
|||
Synonyms |
DEXFENFLURAN; Dexfenfluramine (INN); Redux (TN); (2S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine; (S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Withdrawn from market | [1] | |
Therapeutic Class |
Appetite Depressants
|
|||
Company |
Wyeth Pharmaceuticals
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H16F3N
|
|||
Canonical SMILES |
CCNC(C)CC1=CC(=CC=C1)C(F)(F)F
|
|||
InChI |
1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/t9-/m0/s1
|
|||
InChIKey |
DBGIVFWFUFKIQN-VIFPVBQESA-N
|
|||
CAS Number |
CAS 3239-44-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:439329
|
|||
SuperDrug ATC ID |
A08AA04
|
|||
SuperDrug CAS ID |
cas=003239449
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Serotonin transporter (SERT) | Target Info | Inhibitor | [2] |
KEGG Pathway | Serotonergic synapse | |||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | 5HT1 type receptor mediated signaling pathway | |||
5HT2 type receptor mediated signaling pathway | ||||
5HT3 type receptor mediated signaling pathway | ||||
5HT4 type receptor mediated signaling pathway | ||||
WikiPathways | Monoamine Transport | |||
SIDS Susceptibility Pathways | ||||
NRF2 pathway | ||||
Synaptic Vesicle Pathway | ||||
Serotonin Transporter Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | Obesity: pathophysiology and clinical management. Curr Med Chem. 2009;16(4):506-21. | |||
REF 2 | Serotonergic drugs : effects on appetite expression and use for the treatment of obesity. Drugs. 2007;67(1):27-55. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.